<DOC>
	<DOCNO>NCT01504282</DOCNO>
	<brief_summary>To evaluate safety efficacy 5 second mitomycin-C ( MMC ) application photorefractive keratectomy ( PRK ) patient low myopia .</brief_summary>
	<brief_title>Mitomycin-c Application PRK</brief_title>
	<detailed_description />
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<criteria>The inclusion criterion ablation depth less 65 Âµm , stable refractive error least 1 year correct distance visual acuity ( CDVA ) 0.1 LogMAR good . Patients keratoconus suspect , excessive dry eye , impair wound heal process , lenticular change , corneal dystrophy , history ocular surgery , anterior posterior uveitis , glaucoma retinal disease exclude .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>